Quest Diagnostics Profile

USD 0.01  0.0099%

Quest Diagnostics exotic insider transaction detected

Quest Diagnostics Incorporated insider trading alert for general transaction of common stock by Michael Prevoznik, SVP General Counsel, on April 18, 2018. This event was filed by Quest Diagnostics Inc with SEC on 2013-02-12. Statement of changes in beneficial ownership - SEC Form 4. Michael Prevoznik is currently serves as senior vice president general counsel of Quest Diagnostics In [view details]   

Quest Diagnostics Summary

Quest Diagnostics Incorporated (DGX) is traded on New York Stock Exchange in USA. It is located in NEW JERSEY, U.S.A and employs 45,000 people. Quest Diagnostics is listed under Healthcare category by Fama And French industry classification.The company currently falls under 'Large-Cap' category with total capitalization of 13.69 B. Quest Diagnostics Incorporated runs under Healthcare sector within Medical Equipment industry. This company has 135.78 M outstanding shares of which 5.57 M shares are currently shorted by investors with about 4.24 days to cover shorted positions. QUEST DIAGNOSTC has about 137 M in cash with 811.88 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.01.
Check Quest Diagnostics Probability Of Bankruptcy

Ownership Allocation (%)

Target Price Odds Analysis

Below OddsHorizonTargetAbove Odds
about 31.78%30 days 100.79  about 67.81%
Based on normal probability distribution, the odds of Quest Diagnostics to move above current price in 30 days from now is about 67.81% (This Quest Diagnostics Incorporated probability density function shows the probability of Quest Diagnostics Stock to fall within a particular range of prices over 30 days) .

Top Holders

Selected Quest Diagnostics Incorporated Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Quest Diagnostics Against Markets

Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
< 39% 
Equity ratings for Quest Diagnostics Incorporated are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Quest Diagnostics Incorporated provides diagnostic testing information and services in the United States and internationally. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey. Quest Diagnostics operates under Diagnostics Research classification in USA and traded on New York Stock Exchange. It employs 45000 people. more
Fama & French Healthcare
Fama & French Classification
NameQuest Diagnostics Incorporated
CEOStephen RusckowskiView All
Thematic Classifications
Active Investing Ideas
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Bond Rating
Healthcare, Medical Equipment
InstrumentUSA Stock View All
RegionNorth America
Business Address500 Plaza Drive
ExchangeNew York Stock Exchange
CIK Number01022079.0
IndustryMedical Equipment
Contact Number973 520 2700
CurrencyUSD - US Dollar


Quest Diagnostics Analyst Recommendations
Target PriceAdvice# of Analysts
Quest Diagnostics Incorporated current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Quest Diagnostics Analyst Advice  

Quest Diagnostics Dividends

Upcoming distributions to stockholders


Quest Diagnostics Earnings Estimates
EPSEstimate Date
Quarterly Estimate1.18April 20, 2017
Quest Diagnostics Incorporated normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate  


Quest Diagnostics Corporate Directors
Gail Wilensky Independent Director
Jenne Britell Independent Director
Shawn Bevec Executive Director Investor Relations
Additionally see Investing Opportunities. Please also try Portfolio Reporting module to create custom reports across your portfolios and generate quick suggestion pitch.